VIRT Stock Analysis: Virtu Financial | NYSE
Capital Markets | NYSE, USA | Market Cap: 5.300m USD | 12M Return: 67.2% | US9282541013 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 70.5M
EPS Trend: 98.1%
Qual. Beats: 0
Rev. Trend: 99.1%
Qual. Beats: 12
Warnings
Tailwinds
Seasonality 11.3 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Virtu Financial, Inc. is a New York-headquartered financial services company founded in 2008 and listed on the NYSE since April 2015. It operates in the United States, Ireland, and internationally across two reporting segments: Market Making and Execution Services.
In its Market Making segment, the company buys and sells securities with broker-dealers, banks, and institutions, and routes orders to exchanges, alternative trading systems (ATS), and other market centers. This is the classic liquidity-providing model used by electronic market makers, who earn revenue primarily from the spread between bid and ask prices rather than taking large directional risk.
The Execution Services segment offers agency-based, execution-only trading, workflow technology, trading analytics, and pre- and post-trade services including data products and compliance tools. Coverage spans global equities, ETFs, fixed income, currencies, commodities, foreign exchange, futures, and cryptocurrencies, serving institutional, banking, and broker-dealer clients.
Within the GICS Financials sector and Investment Banking & Brokerage sub-industry, Virtu sits alongside other capital-markets intermediaries whose revenues are tied to trading volumes, volatility, and market activity rather than to balance-sheet lending.
- Market making revenue expands on elevated volatility and trading volumes
- Execution Services growth driven by ETF and fixed income adoption
- Aggressive capital returns continue with dividends and share buybacks
| Net Income: 684.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -1.22 > 1.0 |
| NWC/Revenue: 60.47% < 20% (prev 6.95%; Δ 53.52% < -1%) |
| CFO/TA 0.02 > 3% & CFO 468.0m > Net Income 684.8m |
| Net Debt (9.71b) to EBITDA (1.70b): 5.71 < 3 |
| Current Ratio: 1.11 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.0m) vs 12m ago 1.75% < -2% |
| Gross Margin: 55.45% > 18% (prev 61.77%; Δ -6.32% > 0.5%) |
| Asset Turnover: 17.45% > 50% (prev 17.52%; Δ -0.07% > 0%) |
| Interest Coverage Ratio: 5.11 > 6 (EBIT TTM 1.59b / Interest Expense TTM 310.2m) |
| A: 0.09 (Total Current Assets 25.2b - Total Current Liabilities 22.7b) / Total Assets 27.5b |
| B: 0.06 (Retained Earnings 1.75b / Total Assets 27.5b) |
| C: 0.07 (EBIT TTM 1.59b / Avg Total Assets 23.4b) |
| D: 0.07 (Book Value of Equity 1.87b / Total Liabilities 25.2b) |
| Altman-Z'' = 1.33 = BB |
| DSRI: 1.72 (Receivables 3.52b/1.70b, Revenue 4.08b/3.38b) |
| GMI: 1.11 (GM 61.77% / 55.45%) |
| AQI: 0.08 (AQ_t 0.07 / AQ_t-1 0.86) |
| SGI: 1.21 (Revenue 4.08b / 3.38b) |
| TATA: 0.01 (NI 684.8m - CFO 468.0m) / TA 27.5b) |
| Beneish M = -2.73 (Cap -4..+1) = A |
As of August 22, 2026, the stock is trading at USD 67.93 with a total of 3,009,732 shares traded. Over the past week, the price has changed by +13.18%, over one month by +17.93%, over three months by +29.40% and over the past year by +67.17%.
Current recommended Stop Loss: 64.00 (which is 5.8% or 1.4 ATR below the current price).
Virtu Financial has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold VIRT.
- StrongBuy: 2
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 66.7 | -1.8% |
P/E Trailing = 9.9701
P/E Forward = 9.8135
P/S = 1.6239
P/B = 2.8375
P/EG = -9.42
Revenue TTM = 4.08b USD
EBIT TTM = 1.59b USD
EBITDA TTM = 1.70b USD
Long Term Debt = 10.2b USD (from longTermDebt, last quarter)
Short Term Debt = 353.9m USD (from shortTermDebt, last quarter)
Debt = 10.8b USD (corrected: LT Debt 10.2b + ST Debt 353.9m) + Leases 253.2m
Net Debt = 9.71b USD (calculated: Debt 10.8b - CCE 1.07b)
Enterprise Value = 15.0b USD (5.30b + Debt 10.8b - CCE 1.07b)
Interest Coverage Ratio = 5.11 (Ebit TTM 1.59b / Interest Expense TTM 310.2m)
EV/FCF = 36.78x (Enterprise Value 15.0b / FCF TTM 408.0m)
FCF Yield = 2.72% (FCF TTM 408.0m / Enterprise Value 15.0b)
FCF Margin = 10.00% (FCF TTM 408.0m / Revenue TTM 4.08b)
Net Margin = 16.78% (Net Income TTM 684.8m / Revenue TTM 4.08b)
Gross Margin = 55.45% ((Revenue TTM 4.08b - Cost of Revenue TTM 1.82b) / Revenue TTM)
Gross Margin QoQ = 50.13% (prev 62.40%)
Tobins Q-Ratio = 0.55 (Enterprise Value 15.0b / Total Assets 27.5b)
Interest Expense / Debt = 2.88% (Interest Expense 310.2m / Debt 10.8b)
Taxrate = 16.84% (214.9m / 1.28b)
NOPAT = 1.32b (EBIT 1.59b * (1 - 16.84%))
Current Ratio = 1.11 (Total Current Assets 25.2b / Total Current Liabilities 22.7b)
Debt / Equity = 5.77 (Debt 10.8b / totalStockholderEquity, last quarter 1.87b)
Debt / EBITDA = 5.71 (Net Debt 9.71b / EBITDA 1.70b)
Debt / FCF = 23.80 (Net Debt 9.71b / FCF TTM 408.0m)
Total Stockholder Equity = 1.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.93% (Net Income 684.8m / Total Assets 27.5b)
RoE = 41.25% (Net Income TTM 684.8m / Total Stockholder Equity 1.66b)
RoCE = 13.41% (EBIT 1.59b / Capital Employed (Equity 1.66b + L.T.Debt 10.2b))
RoIC = 26.78% (NOPAT 1.32b / Invested Capital 4.93b)
WACC = 4.04% (E(5.30b)/V(16.1b) * Re(7.40%) + D(10.8b)/V(16.1b) * Rd(2.88%) * (1-Tc(0.17)))
Discount Rate = 7.40% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -67.44 | Cagr: -0.99%
[DCF] Terminal Value 73.10% ; FCFF base≈453.5m ; Y1≈397.7m ; Y5≈321.3m
[DCF] Fair Price = N/A (negative equity: EV 5.16b - Net Debt 9.71b = -4.55b; debt exceeds intrinsic value)
EPS Correlation: 98.12 | EPS CAGR: 72.08% | SUE: -0.53 | # QB: 0
Revenue Correlation: 99.06 | Revenue CAGR: 26.80% | SUE: 0.94 | # QB: 12
EPS current Quarter (2026-09-30): EPS=1.56 | Chg30d=+16.96% | Revisions=+44% | Analysts=6
EPS current Year (2026-12-31): EPS=7.30 | Chg30d=+12.44% | Revisions=+62% | GrowthEPS=+27.4% | GrowthRev=+27.2%
EPS next Year (2027-12-31): EPS=6.93 | Chg30d=+16.45% | Revisions=+70% | GrowthEPS=-5.1% | GrowthRev=-6.1%
[Analyst] Revisions Ratio: +76% (up=17, down=1)